• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSR1抑制前列腺癌的肿瘤生长和转移。

CSR1 suppresses tumor growth and metastasis of prostate cancer.

作者信息

Yu Guoying, Tseng George C, Yu Yan Ping, Gavel Tim, Nelson Joel, Wells Alan, Michalopoulos George, Kokkinakis Demetrius, Luo Jian-Hua

机构信息

Department of Pathology, University of Pittsburgh School of Medicine, 3550 Terrace Street, Pittsburgh, PA 15261, USA.

出版信息

Am J Pathol. 2006 Feb;168(2):597-607. doi: 10.2353/ajpath.2006.050620.

DOI:10.2353/ajpath.2006.050620
PMID:16436673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1606498/
Abstract

Prostate cancer is frequent among men over 45 years of age, but it generally only becomes lethal with metastasis. In this study, we identified a gene called cellular stress response 1 (CSR1) that was frequently down-regulated and methylated in prostate cancer samples. Survival analysis indicated that methylation of the CSR1 promoter, and to a lesser extent down-regulation of CSR1 protein expression, was associated with a high rate of prostate cancer metastasis. Forced expression of CSR1 in prostate cancer cell lines DU145 and PC3 resulted in a two- to threefold decrease in colony formation and a 10-fold reduction in anchorage-independent growth. PC3 cells stably expressing CSR1 had an average threefold decrease in their ability to invade in vitro. Expression of CSR1 in PC3 cell xenografts produced a dramatic reduction (>8-fold) in tumor size, rate of invasion (0 versus 31%), and mortality (13 versus 100%). The present findings suggest that CSR1 is a potent tumor sup-pressor gene.

摘要

前列腺癌在45岁以上男性中很常见,但通常只有在发生转移时才会致命。在本研究中,我们鉴定出一种名为细胞应激反应1(CSR1)的基因,该基因在前列腺癌样本中经常下调并发生甲基化。生存分析表明,CSR1启动子的甲基化以及CSR1蛋白表达的下调(程度较轻)与前列腺癌转移的高发生率相关。在前列腺癌细胞系DU145和PC3中强制表达CSR1导致集落形成减少两到三倍,非锚定依赖性生长减少10倍。稳定表达CSR1的PC3细胞体外侵袭能力平均降低三倍。在PC3细胞异种移植中表达CSR1可使肿瘤大小、侵袭率(从31%降至0)和死亡率(从100%降至13%)显著降低。目前的研究结果表明,CSR1是一种有效的肿瘤抑制基因。

相似文献

1
CSR1 suppresses tumor growth and metastasis of prostate cancer.CSR1抑制前列腺癌的肿瘤生长和转移。
Am J Pathol. 2006 Feb;168(2):597-607. doi: 10.2353/ajpath.2006.050620.
2
Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression.miR-650在前列腺癌中的致癌活性是通过抑制CSR1表达介导的。
Am J Pathol. 2015 Jul;185(7):1991-9. doi: 10.1016/j.ajpath.2015.03.015. Epub 2015 May 5.
3
Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.SUMO化负向调控CSR1依赖性前列腺癌细胞死亡。
Cell Physiol Biochem. 2018;46(5):1861-1867. doi: 10.1159/000489370. Epub 2018 Apr 25.
4
Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.谷胱甘肽过氧化物酶3在前列腺癌中缺失或甲基化,可抑制前列腺癌的生长和转移。
Cancer Res. 2007 Sep 1;67(17):8043-50. doi: 10.1158/0008-5472.CAN-07-0648.
5
Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.前列腺癌、肝癌、多形性胶质母细胞瘤和平滑肌肉瘤中整合素α7突变的分析。
J Natl Cancer Inst. 2007 Jun 6;99(11):868-80. doi: 10.1093/jnci/djk199.
6
Methylation of the CD44 metastasis suppressor gene in human prostate cancer.人前列腺癌中CD44转移抑制基因的甲基化
Cancer Res. 1999 May 15;59(10):2329-31.
7
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.人前列腺癌转移至人骨的严重联合免疫缺陷-人模型
Cancer Res. 1999 Apr 15;59(8):1987-93.
8
CSR1 induces cell death through inactivation of CPSF3.CSR1通过使CPSF3失活诱导细胞死亡。
Oncogene. 2009 Jan 8;28(1):41-51. doi: 10.1038/onc.2008.359. Epub 2008 Sep 22.
9
CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.LNCaP和Tramp - C1前列腺癌细胞系中14 - 3 - 3σ基因表达的CpG岛启动子甲基化和沉默与甲基化CpG结合蛋白MBD2相关。
Oncogene. 2006 Aug 3;25(33):4559-72. doi: 10.1038/sj.onc.1209462. Epub 2006 Jun 19.
10
Cellular stress response 1 down-regulates the expression of epidermal growth factor receptor and platelet-derived growth factor receptor through inactivation of splicing factor 3A3.细胞应激反应1通过使剪接因子3A3失活来下调表皮生长因子受体和血小板衍生生长因子受体的表达。
Mol Carcinog. 2017 Feb;56(2):315-324. doi: 10.1002/mc.22494. Epub 2016 May 5.

引用本文的文献

1
Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction.铁霉素通过靶向铁代谢成瘾诱导套细胞淋巴瘤细胞死亡。
Theranostics. 2025 Feb 3;15(7):2834-2851. doi: 10.7150/thno.101821. eCollection 2025.
2
SR-A3 suppresses AKT activation to protect against MAFLD by inhibiting XIAP-mediated PTEN degradation.清道夫受体A3通过抑制X连锁凋亡抑制蛋白介导的磷酸酶和张力蛋白同源物降解来抑制AKT激活,从而预防非酒精性脂肪性肝炎。
Nat Commun. 2025 Mar 11;16(1):2430. doi: 10.1038/s41467-025-57585-0.
3
Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells.接触二氧化钛产品会改变人类细胞中的DNA甲基化。
Nanomaterials (Basel). 2024 Dec 19;14(24):2037. doi: 10.3390/nano14242037.
4
Immuno-targeting the ectopic phosphorylation sites of PDGFRA generated by MAN2A1-FER fusion in HCC.针对 HCC 中 MAN2A1-FER 融合产生的 PDGFRA 异位磷酸化位点进行免疫靶向治疗。
Hepatol Commun. 2024 Jul 31;8(8). doi: 10.1097/HC9.0000000000000511. eCollection 2024 Aug 1.
5
Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine Learning.基于机器学习的血清融合转录本评估肝细胞癌风险和癌症治疗影响。
Am J Pathol. 2024 Jul;194(7):1262-1271. doi: 10.1016/j.ajpath.2024.02.017. Epub 2024 Mar 25.
6
Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing.通过 Cas9 介导的编辑将 HSV1 胸苷激酶插入基因组突变的肝癌的治疗靶向。
Hepatol Commun. 2024 Mar 18;8(4). doi: 10.1097/HC9.0000000000000412. eCollection 2024 Apr 1.
7
Integrating TCGA and single-cell sequencing data for colorectal cancer: a 10-gene prognostic risk assessment model.整合TCGA和单细胞测序数据用于结直肠癌:一种10基因预后风险评估模型
Discov Oncol. 2023 Sep 13;14(1):168. doi: 10.1007/s12672-023-00789-x.
8
SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer.SCARA3 通过 AKT 信号通路抑制肺癌细胞增殖和 EMT。
BMC Cancer. 2022 May 16;22(1):552. doi: 10.1186/s12885-022-09631-z.
9
PepFect14 Signaling and Transfection.PepFect14 信号转导与转染。
Methods Mol Biol. 2022;2383:229-246. doi: 10.1007/978-1-0716-1752-6_15.
10
DICER-AS1 functions as competing endogenous RNA that targets CSR1 by sponging microRNA-650 and suppresses gastric cancer progression.DICER-AS1 作为竞争性内源性 RNA,通过海绵吸附 microRNA-650 靶向 CSR1,抑制胃癌进展。
J Int Med Res. 2021 Sep;49(9):3000605211041466. doi: 10.1177/03000605211041466.

本文引用的文献

1
Cancer statistics, 2005.2005年癌症统计数据。
CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30. doi: 10.3322/canjclin.55.1.10.
2
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.前列腺癌中的基因表达改变可预测肿瘤侵袭性及恶性肿瘤的前期发展。
J Clin Oncol. 2004 Jul 15;22(14):2790-9. doi: 10.1200/JCO.2004.05.158.
3
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.DLC-1在人类非小细胞肺癌中作为一种肿瘤抑制基因发挥作用。
Oncogene. 2004 Feb 19;23(7):1405-11. doi: 10.1038/sj.onc.1207291.
4
Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.肝细胞癌中DLC-1基因的遗传和表观遗传改变
Cancer Res. 2003 Nov 15;63(22):7646-51.
5
Genetic factors underlying prostate cancer.
Expert Rev Mol Med. 2003 Apr 15;5(12):1-26. doi: 10.1017/S1462399403006057.
6
The CpG island searcher: a new WWW resource.CpG岛搜索器:一种新的万维网资源。
In Silico Biol. 2003;3(3):235-40.
7
DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.DLC-1基因抑制人乳腺癌细胞生长及体内致瘤性。
Oncogene. 2003 Jan 23;22(3):445-50. doi: 10.1038/sj.onc.1206064.
8
DBC2, a candidate for a tumor suppressor gene involved in breast cancer.DBC2,一种参与乳腺癌的肿瘤抑制基因候选基因。
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13647-52. doi: 10.1073/pnas.212516099. Epub 2002 Oct 7.
9
Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.前列腺癌的综合基因表达分析揭示了与转移性疾病相关的不同转录程序。
Cancer Res. 2002 Aug 1;62(15):4499-506.
10
Gene expression analysis of prostate cancers.
Mol Carcinog. 2002 Jan;33(1):25-35. doi: 10.1002/mc.10018.